Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

NCT00003674 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

141

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Veno-occlusive Disease

Interventions

DRUG: dalteparin
DRUG: standard therapy

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]